Follow
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Job PurposeThe Clinical Development Lead (CDL) in Japan is the single point of accountability for all clinical development activities for assigned asset(s). The CDL provides scientific and medical leadership to define and deliver Japan clinical strategy drives innovation and decisionm
Job PurposeThe Clinical Development Lead (CDL) in Japan is the single point of accountability for all clinical development activities for assigned asset(s). The CDL provides scientific and medical leadership to define and deliver Japan clinical strategy drives innovation and decisionm
Central Region: TX CO AZ UT OK AR WY and portions of NM NV KS WA ID IAViiV Healthcare is a global specialty HIV company the only one that is 100% focused on researching and delivering new medicines for people living with and at risk of HIV. ViiV is highly mission-driven in our unrelen
Central Region: TX CO AZ UT OK AR WY and portions of NM NV KS WA ID IAViiV Healthcare is a global specialty HIV company the only one that is 100% focused on researching and delivering new medicines for people living with and at risk of HIV. ViiV is highly mission-driven in our unrelen
Territory to Include but not limited to: Oklahoma City Edmond and NormanRelocation assistance is not providedBusiness IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing s
Territory to Include but not limited to: Oklahoma City Edmond and NormanRelocation assistance is not providedBusiness IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing s
At GSKs flagship manufacturing site at Ware (Hertfordshire) we are now looking for a Product Performance Lead to manage a team responsible for the local delivery (at the Ware site) of the technical lifecyclePlan. This role sits within the sites Manufacturing Science and Technology (MS
At GSKs flagship manufacturing site at Ware (Hertfordshire) we are now looking for a Product Performance Lead to manage a team responsible for the local delivery (at the Ware site) of the technical lifecyclePlan. This role sits within the sites Manufacturing Science and Technology (MS
Position SummaryThis key Non-Clinical Safety Leadership role will actas a Project Team Member consultant mentor and reviewer across discovery and development projects. Accountable for the quality of scientific thinking and outputs that characterise non-clinical safety drug disposition
Position SummaryThis key Non-Clinical Safety Leadership role will actas a Project Team Member consultant mentor and reviewer across discovery and development projects. Accountable for the quality of scientific thinking and outputs that characterise non-clinical safety drug disposition
The territory for this role includes Ohio Michigan and Indianapolis.GSK ONCOLOGYGSK is a place to build a career in Oncology where purpose science and growth come together. As a focused global biopharma company we unite science technology and talent to get ahead of disease together w
The territory for this role includes Ohio Michigan and Indianapolis.GSK ONCOLOGYGSK is a place to build a career in Oncology where purpose science and growth come together. As a focused global biopharma company we unite science technology and talent to get ahead of disease together w
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol
Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Are you energized by a procurement role that allows you to leverage technology and accelerate efficiency and best practices across the business If so this Senior R&D Procurement Manager role could be an ideal opportunity to explore.Job PurposeAs a Senior R&D Procurement Manager in Cli
Are you energized by a procurement role that allows you to leverage technology and accelerate efficiency and best practices across the business If so this Senior R&D Procurement Manager role could be an ideal opportunity to explore.Job PurposeAs a Senior R&D Procurement Manager in Cli
Business Introduction:GSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patien
Business Introduction:GSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patien
Job Purpose:The Transformation Delivery Director will be the accountable point of contact for the execution of an assigned strategic program including the upfront shaping and set-up of program and the delivery to the point of Business As Usual (BAU). They will set up programs with a c
Job Purpose:The Transformation Delivery Director will be the accountable point of contact for the execution of an assigned strategic program including the upfront shaping and set-up of program and the delivery to the point of Business As Usual (BAU). They will set up programs with a c
Territory to Include but not limited to Poughkeepsie NY.At GSK we have already delivered unprecedented change over the past four years improving R&D strengthening our leadership and transforming our commercial execution. We have a leading portfolio of vaccines and specialty medicines
Territory to Include but not limited to Poughkeepsie NY.At GSK we have already delivered unprecedented change over the past four years improving R&D strengthening our leadership and transforming our commercial execution. We have a leading portfolio of vaccines and specialty medicines
The territory for this role includes Oregon Nevada Washington State Utah Montana Idaho and North CA.GSK ONCOLOGYGSK is a place to build a career in Oncology where purpose science and growth come together. As a focused global biopharma company we unite science technology and talent to
The territory for this role includes Oregon Nevada Washington State Utah Montana Idaho and North CA.GSK ONCOLOGYGSK is a place to build a career in Oncology where purpose science and growth come together. As a focused global biopharma company we unite science technology and talent to
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
At GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system with cutting-edge technology to trans
At GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system with cutting-edge technology to trans
